Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial

Neurology

Volumn 57, Issue 12 SUPPL. 5, 2001, Pages

  Duquette, P ^a   Girard, M ^a   Despault, L ^a   Dubois, R ^a   Knobler, R L ^a   Lublin, F D ^a   Kelley, L ^a   Francis, G S ^a   Lapierre, Y ^a   Antel, J ^a   Freedman, M ^a   Hum, S ^a   Greenstein, J I ^a   Mishra, B ^a   Muldoon, J ^a   Whitaker, J N ^a   Evans, B K ^a   Layton, B ^a   Sibley, W A ^a   Laguna, J ^a   Krikawa, J ^a   Paty, D W ^a   Oger, J J ^a   Kastrukoff, L F ^a   Moore, W ^a   Hashimoto, S A ^a   Morrison, W ^a   Nelson, J ^a   Goodin, D S ^a   Massa, S M ^a   Gutteridge, E ^a   Arnason, B G W ^a   Noronha, A ^a   Reder, A T ^a   Martia, R ^a   Ebers, G C ^a   Rice, G P A ^a   Lesaux, J ^a   Johnson, K P ^a   Panitch, H S ^a   Bever, C T ^a   Conway, K ^a   Constine, J ^a   Lisa, W ^a   Van den Noort, S ^a   Weinshenker, B ^a   Weiss, W ^a   Reingold, S ^a   Pachner, A ^a   Taylor, W ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON BETA SERINE; PLACEBO; BETA INTERFERON; BETA1A INTERFERON; INTERFERON BETA-1B;

ADULT; AMBULATORY CARE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; HISTORY;

FEMALE; HISTORY, 20TH CENTURY; HUMANS; INTERFERON-BETA; MALE; MULTICENTER STUDIES; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RANDOMIZED CONTROLLED TRIALS;

EID: 0035956586     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Immunology of multiple sclerosis
2. Immunology of multiple sclerosis
3. Nuclear magnetic resonance imaging of the brain in multiple sclerosis
4. Serial magnetic resonance scanning in multiple sclerosis; a second prospective study in relapsing patients
5. Intrathecally administered natural human fibroblast interferon reduces exacerbations of multiple sclerosis: Results of a multicenter, double-blinded study
6. Systemic alpha-interferon therapy of multiple sclerosis
7. Systemic recombinant alpha 2 interferon therapy in relapsing multiple sclerosis
8. Clinical viral infections and multiple sclerosis
9. Upper respiratory tract infections trigger attacks of multiple sclerosis in patients treated with interferon-beta
10. A prospective study of physical trauma and multiple sclerosis
11. Recombinant human beta interferon treatment of relapsing-remitting multiple sclerosis: Pilot study results
12. New diagnostic criteria for multiple sclerosis
13. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
14. A neurologic rating scale (NRS) for use in multiple sclerosis
15. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial
16. IFN-beta down-regulates IFN-gamma production by activated T cells in MS
17. Recombinant beta interferon inhibits gamma interferon production in multiple sclerosis
18. Interferon beta augments suppressor cell function in multiple sclerosis
19. Interferon beta specifically inhibits interferon-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line
20. Beta interferon prevents HLA class II antigen induction by gamma interferon in MS
21. Interferon-beta treatment does not elevate cortisol in multiple sclerosis
22. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
23. Attempts to transmit multiple sclerosis to non-human primates
24. Virus-induced demyelination in man: Models for multiple sclerosis
25. The natural history of multiple sclerosis: A geographically based study. 2. Predictive value of the early clinical course